300194 Stock Overview
Research and develops, produces, and sells chemical drugs in the People's Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Fuan Pharmaceutical (Group) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.97 |
| 52 Week High | CN¥5.68 |
| 52 Week Low | CN¥2.92 |
| Beta | 0.25 |
| 11 Month Change | 3.11% |
| 3 Month Change | 27.76% |
| 1 Year Change | 7.11% |
| 33 Year Change | 20.63% |
| 5 Year Change | -1.58% |
| Change since IPO | -27.51% |
Recent News & Updates
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Shares Fly 36% But Investors Aren't Buying For Growth
Oct 08
There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings
Aug 23Recent updates
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Shares Fly 36% But Investors Aren't Buying For Growth
Oct 08There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings
Aug 23Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?
Jun 07Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit
May 02Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price
Apr 03Shareholder Returns
| 300194 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.1% | -5.2% | -4.1% |
| 1Y | 7.1% | -6.7% | 3.8% |
Return vs Industry: 300194 exceeded the CN Pharmaceuticals industry which returned -6.7% over the past year.
Return vs Market: 300194 exceeded the CN Market which returned 3.8% over the past year.
Price Volatility
| 300194 volatility | |
|---|---|
| 300194 Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300194 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300194's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3,292 | Lu Wang | www.fapharm.com |
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd.
Fuan Pharmaceutical (Group) Co., Ltd. Fundamentals Summary
| 300194 fundamental statistics | |
|---|---|
| Market cap | CN¥5.91b |
| Earnings (TTM) | CN¥281.63m |
| Revenue (TTM) | CN¥2.66b |
21.0x
P/E Ratio2.2x
P/S RatioIs 300194 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300194 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.66b |
| Cost of Revenue | CN¥1.34b |
| Gross Profit | CN¥1.32b |
| Other Expenses | CN¥1.04b |
| Earnings | CN¥281.63m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 49.60% |
| Net Profit Margin | 10.59% |
| Debt/Equity Ratio | 16.1% |
How did 300194 perform over the long term?
See historical performance and comparison